Zimmer Biomet Holdings (ZBH) Notes Payables (2011 - 2022)

Zimmer Biomet Holdings (ZBH) recorded quarterly Notes Payables of $83.0 million in Q4 2022, up 16500.0% quarter-over-quarter from $500000.0 in Q4 2013.

Zimmer Biomet Holdings (ZBH) Notes Payables (2011 - 2022) Analysis & Trends

Zimmer Biomet Holdings' Notes Payables history runs 4 years deep, the most recent figure standing at $83.0 million for Q4 2022.

  • In Q4 2022, Notes Payables changed N/A year-over-year to $83.0 million; the TTM figure through Dec 2022 stood at $83.0 million (changed N/A YoY), while the FY2022 annual figure was $83.0 million, changed N/A from the prior year.
  • Notes Payables was $83.0 million for Q4 2022 at Zimmer Biomet Holdings, up from $500000.0 in the prior quarter.
  • In the past five years, Notes Payables ranged from a high of $83.0 million in Q4 2022 to a low of $83.0 million in Q4 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn
10 Zimmer Biomet Holdings 17.18 Bn 16.77 Bn 1.51 Bn

Historic Data

Download Data
DateValue
Dec 31, 2022 83.00 Mn
Dec 31, 2013 500,000.00
Dec 31, 2012 100.10 Mn
Sep 30, 2012 300,000.00
Jun 30, 2012 3.40 Mn
Mar 31, 2012 144.60 Mn
Dec 31, 2011 143.30 Mn